ZNF696 Inhibitors
Zinc finger protein 696 (ZNF696) is a member of the zinc finger protein family, characterized by the presence of zinc finger domains, which are motifs often found in DNA-binding proteins. These domains are so named because they coordinate zinc ions to stabilize their structure. Zinc finger domains consist of a sequence of amino acids that form a loop around a zinc ion, typically with the configuration of cysteine and histidine residues that bind the zinc.
ZNF696 contains multiple C2H2-type zinc fingers, which are the most common type of zinc finger domain found in eukaryotic transcription factors. Each C2H2 finger typically has a beta-beta-alpha fold that grips the zinc ion and uses the alpha helix to make contact with DNA. The specific DNA-binding properties of ZNF696 are determined by the amino acid sequence within its zinc finger domains, which dictate the protein's ability to bind to particular DNA sequences.The role of ZNF696 as a transcription factor likely involves the regulation of gene expression by binding to DNA at promoter or enhancer regions. Through such interactions, ZNF696 can potentially activate or repress the transcription of target genes, influencing diverse cellular processes, including growth, differentiation, and response to various stimuli.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $130.00 | 10 | |
Zinc chelators like TPEN might indirectly affect ZNF696 by altering zinc availability, crucial for the function of zinc finger proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitors such as Trichostatin A could indirectly influence ZNF696 by modifying chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may affect ZNF696 indirectly by altering gene expression patterns through DNA methylation changes. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK/STAT inhibitors like Ruxolitinib could indirectly impact ZNF696 by modulating pathways involved in gene expression and cell signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, a PI3K/Akt/mTOR inhibitor, might affect ZNF696 indirectly by altering signaling pathways that intersect with DNA binding and gene regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitors like JQ1 may influence ZNF696 indirectly by affecting transcription regulation and chromatin remodeling. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
HSP90 inhibitors like 17-AAG could indirectly influence ZNF696 by affecting protein stability and function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Splicing inhibitors such as Pladienolide B may indirectly impact ZNF696 by altering RNA splicing processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin, an RNA polymerase inhibitor, could indirectly affect ZNF696 by impacting RNA synthesis and processing. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitors like Bortezomib may influence ZNF696 indirectly by modulating protein degradation pathways. | ||||||